Research carried out by the group of Myocardial Dysfunction and Heart Transplantation Institute of Health Research of Hospital Universitario La Fe, Valencia (IIS-La Fe), directed by Miguel Rivera, in collaboration with Puerta de Hierro Madrid Hospital and Clínico Universitario de Santiago de Compostela and the company Sistemas Genómicos, could serve as a basis for future gene therapy applied to modulate the impaired muscle contraction in patients with dilated cardiomyopathy.

Más información

sistemas genómicos
Privacy Summary

This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful. You can access our privacy policy here